| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -3.8e-06 | 1 |